Astera Labs Forecast, price target & analysts
Why the stock moved Beta
Astera Labs Target price 2026 - Analyst rating & recommendation
Astera Labs Classifications & Recommendation
Astera Labs Price Target
| Target Price | $433.50 |
| Price | $293.56 |
| Potential | 47.67% |
| Number of Estimates | 24 |
| 24 Analysts have issued a price target Astera Labs 2027 . The average Astera Labs target price is $433.50. This is 47.67% higher than the current stock price. The highest price target is $525.00 78.84% , the lowest is $191.90 34.63% . | |
| A rating was issued by 29 analysts: 21 Analysts recommend Astera Labs to buy, 8 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Astera Labs stock has an average upside potential 2027 of 47.67% . Most analysts recommend the Astera Labs stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2030
26 Analysts have issued a sales forecast Astera Labs 2026 . The average Astera Labs sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an Astera Labs EBITDA forecast 2026. The average Astera Labs EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
26 Astera Labs Analysts have issued a net profit forecast 2026. The average Astera Labs net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
26 Analysts have issued a Astera Labs forecast for earnings per share. The average Astera Labs EPS is
This results in the following potential growth metrics and future valuations:
Current Astera Labs Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Northland Capital Markets |
Market Perform
➜
Outperform
|
Upgrade | Aug 17 2026 |
| Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Aug 05 2026 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Aug 05 2026 |
| Needham |
Buy
➜
Buy
|
Unchanged | Aug 05 2026 |
| Jefferies |
Buy
➜
Buy
|
Unchanged | Aug 05 2026 |
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Aug 05 2026 |
| TD Cowen |
Hold
➜
Hold
|
Unchanged | Aug 05 2026 |
| Analyst Rating | Date |
|---|---|
|
Upgrade
Northland Capital Markets:
Market Perform
➜
Outperform
|
Aug 17 2026 |
|
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Aug 05 2026 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Aug 05 2026 |
|
Unchanged
Needham:
Buy
➜
Buy
|
Aug 05 2026 |
|
Unchanged
Jefferies:
Buy
➜
Buy
|
Aug 05 2026 |
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Aug 05 2026 |
|
Unchanged
TD Cowen:
Hold
➜
Hold
|
Aug 05 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
